Archive 4 checkpoints (1-4)
Browse files- paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/analysis/benchmark/ye2026_sepsis/AGGREGATE.md +26 -0
- paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/analysis/compare_k1000/imperial_eskd/SUMMARY.md +42 -0
- paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/analysis/compare_k1000/ye2026_sepsis/SUMMARY.md +43 -0
- paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/K_BUILD.json +112 -0
paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/analysis/benchmark/ye2026_sepsis/AGGREGATE.md
ADDED
|
@@ -0,0 +1,26 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# ye2026_sepsis: LoRA-5 at K = 4,000 vs K = 1,000 on the paired benchmark (5 draws)
|
| 2 |
+
|
| 3 |
+
Same five few-pair draws (same 5 training donors each), same test donors, same scorer (paired_finetune_intradataset_20260927/tools/score_ft.py), 1,500 cells per test sample. Mean ± SD over draws.
|
| 4 |
+
|
| 5 |
+
| metric | LoRA-5, K = 1,000 (benchmark) | LoRA-5, K = 4,000 | K4000 − K1000 (draws better / n) |
|
| 6 |
+
|---|---:|---:|---|
|
| 7 |
+
| comp_l1 | 0.466 ± 0.044 | 0.445 ± 0.051 | -0.022 (4 / 5) |
|
| 8 |
+
| precision | 0.906 ± 0.020 | 0.910 ± 0.019 | +0.004 (2 / 5) |
|
| 9 |
+
| coverage | 0.694 ± 0.042 | 0.698 ± 0.035 | +0.004 (3 / 5) |
|
| 10 |
+
| coverage_dm | 0.834 ± 0.023 | 0.836 ± 0.023 | +0.001 (2 / 5) |
|
| 11 |
+
| pb_r_median | 0.883 ± 0.003 | 0.884 ± 0.003 | +0.001 (3 / 5) |
|
| 12 |
+
| mono_pct_gen | 17.839 ± 9.673 | 18.706 ± 10.052 | +0.867 (2 / 5) |
|
| 13 |
+
| mono_pct_obs | 20.689 ± 0.444 | 20.689 ± 0.444 | +0.000 |
|
| 14 |
+
| median_umi_gen | 1728.600 ± 189.579 | 1781.200 ± 169.896 | +52.600 (2 / 5) |
|
| 15 |
+
| median_umi_obs | 1971.000 ± 18.841 | 1971.000 ± 18.841 | +0.000 |
|
| 16 |
+
| deg_top50_sum | 16.400 ± 6.731 | 17.800 ± 9.445 | +1.400 (2 / 5) |
|
| 17 |
+
| deg_top50_sum_broadcast | 20.000 ± 1.871 | 20.000 ± 1.871 | +0.000 |
|
| 18 |
+
| logfc_r_gen | 0.350 ± 0.162 | 0.327 ± 0.128 | -0.023 (2 / 5) |
|
| 19 |
+
| logfc_r_broadcast | 0.320 ± 0.024 | 0.320 ± 0.024 | +0.000 |
|
| 20 |
+
| logfc_partial_r | 0.305 ± 0.189 | 0.276 ± 0.160 | -0.029 (2 / 5) |
|
| 21 |
+
|
| 22 |
+
Per donor-draw composition L1, K = 4,000 − K = 1,000: -0.0215; K = 4,000 is better in 57% of 385 donor-draws (Wilcoxon p 0.0054).
|
| 23 |
+
|
| 24 |
+
Lower is better for comp_l1; closer to *_obs is better for mono_pct_gen and median_umi_gen; higher is better for precision, coverage, pseudobulk r, the logFC r values and the top-50 DEG overlap. *_obs and *broadcast rows are the same for both arms (observed truth / bulk baseline).
|
| 25 |
+
|
| 26 |
+
Scorer check: this plan's K = 1,000 arm vs the benchmark's stored draw scores, max |difference| per draw: draw0 0 (25 metrics), draw1 0 (25 metrics), draw2 0 (25 metrics), draw3 0 (25 metrics), draw4 0 (25 metrics).
|
paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/analysis/compare_k1000/imperial_eskd/SUMMARY.md
ADDED
|
@@ -0,0 +1,42 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# imperial_eskd: paired-test calibration, LoRA-5 K = 4,000 vs K = 1,000
|
| 2 |
+
|
| 3 |
+
50 features x 5 draws = 250 pairs (same draws, test samples and observed truth). Level ok: ratio 0.5-2 and Spearman >= 0.3. Contrast ok: same sign and |generated difference| within 0.5-2x of observed.
|
| 4 |
+
|
| 5 |
+
| draw | level ok K1000 | level ok K4000 | COVID+ vs COVID- ok K1000 | K4000 | severe/critical vs mild/moderate (COVID+) ok K1000 | K4000 |
|
| 6 |
+
|---|---:|---:|---:|---:|---:|---:|
|
| 7 |
+
| 0 | 21 | 23 | 19 | 18 | 18 | 20 |
|
| 8 |
+
| 1 | 24 | 19 | 20 | 24 | 18 | 19 |
|
| 9 |
+
| 2 | 25 | 25 | 19 | 20 | 20 | 18 |
|
| 10 |
+
| 3 | 25 | 22 | 21 | 22 | 15 | 11 |
|
| 11 |
+
| 4 | 16 | 21 | 20 | 22 | 15 | 18 |
|
| 12 |
+
| all | 111 | 110 | 99 | 106 | 86 | 86 |
|
| 13 |
+
|
| 14 |
+
- |log2 ratio| (distance of the generated level from observed), K4000 − K1000: median +0.008; closer in 48% of 250 pairs.
|
| 15 |
+
- Spearman over test samples, K4000 − K1000: median +0.026; higher in 68% of 250 pairs.
|
| 16 |
+
- COVID+ vs COVID-: same sign in 214 (K1000) vs 214 (K4000) of 250 pairs.
|
| 17 |
+
- severe/critical vs mild/moderate (COVID+): same sign in 187 (K1000) vs 191 (K4000) of 250 pairs.
|
| 18 |
+
|
| 19 |
+
Level gate gained at K4000 (10 features; draws): Cytotoxic CD4 T [1]; l1 | DC [4]; l1 | NK cell [0,2,3]; l2 | CD16 monocyte [4]; l2 | CD56dim NK cell [4]; l2 | Intermediate monocyte [1,2]; l2 | MAIT [0]; l2 | Naive B cell [2]; l2 | Naive CD8 T cell [4]; l2 | Proliferating T cell [4]
|
| 20 |
+
|
| 21 |
+
Level gate lost at K4000 (13 features; draws): Cycling T/NK [2]; ISG-high T [1]; Plasmablast (label) [1]; Plasmablast (markers) [2]; l2 | CD16 monocyte [1]; l2 | Erythrocyte [2]; l2 | MAIT [3]; l2 | Memory B cell [1]; l2 | Plasma cell [1]; l2 | Platelet [3]; l2 | Progenitor cell [1]; l2 | Proliferating T cell [3]; l2 | pDC [1,3]
|
| 22 |
+
|
| 23 |
+
Named features, ratio (Spearman) per draw:
|
| 24 |
+
|
| 25 |
+
| feature | version | d0 | d1 | d2 | d3 | d4 |
|
| 26 |
+
|---|---|---:|---:|---:|---:|---:|
|
| 27 |
+
| l1 | Monocyte | k1000 | 1.08 (0.39) | 0.83 (0.33) | 1.11 (0.35) | 1.21 (0.42) | 0.98 (0.18) |
|
| 28 |
+
| l1 | Monocyte | k4000 | 1.10 (0.45) | 0.91 (0.42) | 1.15 (0.38) | 1.30 (0.48) | 0.98 (0.27) |
|
| 29 |
+
| l1 | NK cell | k1000 | 0.80 (0.20) | 0.43 (0.31) | 0.67 (0.21) | 1.09 (0.25) | 0.82 (0.14) |
|
| 30 |
+
| l1 | NK cell | k4000 | 0.82 (0.31) | 0.40 (0.42) | 0.51 (0.32) | 1.03 (0.30) | 0.84 (0.25) |
|
| 31 |
+
| l1 | DC | k1000 | 0.93 (0.23) | 1.08 (0.17) | 1.18 (0.13) | 0.59 (0.33) | 0.74 (0.28) |
|
| 32 |
+
| l1 | DC | k4000 | 1.00 (0.23) | 1.15 (0.27) | 1.18 (0.21) | 0.66 (0.34) | 0.78 (0.33) |
|
| 33 |
+
| l1 | B cell | k1000 | 0.54 (0.66) | 0.88 (0.54) | 0.82 (0.56) | 0.55 (0.62) | 1.17 (0.57) |
|
| 34 |
+
| l1 | B cell | k4000 | 0.56 (0.67) | 1.00 (0.58) | 0.96 (0.59) | 0.56 (0.66) | 1.22 (0.62) |
|
| 35 |
+
| l1 | T cell | k1000 | 1.13 (0.49) | 1.29 (0.41) | 1.10 (0.48) | 1.05 (0.45) | 1.03 (0.37) |
|
| 36 |
+
| l1 | T cell | k4000 | 1.11 (0.53) | 1.24 (0.52) | 1.10 (0.51) | 1.03 (0.52) | 1.01 (0.49) |
|
| 37 |
+
| l2 | MAIT | k1000 | 0.53 (0.19) | 0.41 (0.29) | 0.44 (0.39) | 0.54 (0.36) | 0.66 (0.15) |
|
| 38 |
+
| l2 | MAIT | k4000 | 0.50 (0.34) | 0.40 (0.31) | 0.40 (0.44) | 0.61 (0.29) | 0.62 (0.15) |
|
| 39 |
+
| l2 | CD14 monocyte | k1000 | 1.04 (0.48) | 1.05 (0.44) | 1.25 (0.42) | 1.21 (0.48) | 0.73 (0.33) |
|
| 40 |
+
| l2 | CD14 monocyte | k4000 | 1.03 (0.50) | 1.24 (0.47) | 1.36 (0.42) | 1.31 (0.51) | 0.71 (0.33) |
|
| 41 |
+
| l2 | Plasma cell | k1000 | 0.23 (0.28) | 0.66 (0.34) | 1.21 (0.20) | 0.61 (0.29) | 0.67 (0.43) |
|
| 42 |
+
| l2 | Plasma cell | k4000 | 0.25 (0.28) | 0.63 (0.29) | 1.56 (0.22) | 0.53 (0.30) | 0.68 (0.46) |
|
paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/analysis/compare_k1000/ye2026_sepsis/SUMMARY.md
ADDED
|
@@ -0,0 +1,43 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# ye2026_sepsis: paired-test calibration, LoRA-5 K = 4,000 vs K = 1,000
|
| 2 |
+
|
| 3 |
+
50 features x 5 draws = 250 pairs (same draws, test samples and observed truth). Level ok: ratio 0.5-2 and Spearman >= 0.3. Contrast ok: same sign and |generated difference| within 0.5-2x of observed.
|
| 4 |
+
|
| 5 |
+
| draw | level ok K1000 | level ok K4000 | adult sepsis vs adult HC ok K1000 | K4000 | adult sepsis vs adult ICU control ok K1000 | K4000 | sepsis vs all controls ok K1000 | K4000 |
|
| 6 |
+
|---|---:|---:|---:|---:|---:|---:|---:|---:|
|
| 7 |
+
| 0 | 21 | 23 | 22 | 20 | 10 | 11 | 14 | 14 |
|
| 8 |
+
| 1 | 18 | 16 | 11 | 13 | 9 | 6 | 12 | 9 |
|
| 9 |
+
| 2 | 16 | 18 | 12 | 16 | 13 | 14 | 14 | 15 |
|
| 10 |
+
| 3 | 22 | 27 | 12 | 20 | 8 | 16 | 13 | 12 |
|
| 11 |
+
| 4 | 23 | 23 | 16 | 14 | 17 | 19 | 15 | 13 |
|
| 12 |
+
| all | 100 | 107 | 73 | 83 | 57 | 66 | 68 | 63 |
|
| 13 |
+
|
| 14 |
+
- |log2 ratio| (distance of the generated level from observed), K4000 − K1000: median -0.008; closer in 54% of 250 pairs.
|
| 15 |
+
- Spearman over test samples, K4000 − K1000: median +0.013; higher in 60% of 250 pairs.
|
| 16 |
+
- adult sepsis vs adult HC: same sign in 193 (K1000) vs 192 (K4000) of 250 pairs.
|
| 17 |
+
- adult sepsis vs adult ICU control: same sign in 170 (K1000) vs 182 (K4000) of 250 pairs.
|
| 18 |
+
- sepsis vs all controls: same sign in 165 (K1000) vs 169 (K4000) of 250 pairs.
|
| 19 |
+
|
| 20 |
+
Level gate gained at K4000 (13 features; draws): ISG-high T [0]; Plasmablast (label) [3]; l1 | Other [2,3]; l1 | T cell [2,3]; l2 | CD56dim NK cell [1]; l2 | DN T cell [0,3]; l2 | Memory B cell [3]; l2 | Naive B cell [0]; l2 | Plasma cell [3]; l2 | Platelet [3]; l2 | Proliferating NK cell [0,2,4]; l2 | Treg [3]; l2 | pDC [3]
|
| 21 |
+
|
| 22 |
+
Level gate lost at K4000 (11 features; draws): C1Q-high monocyte (reference) [4]; ISG-high T [1]; Proliferating T (label) [3]; l1 | Monocyte [0]; l1 | Other [1]; l2 | CD14 monocyte [0]; l2 | Effector B cell [2]; l2 | MAIT [3]; l2 | Platelet [1]; l2 | Proliferating T cell [3]; l2 | cDC2 [3]
|
| 23 |
+
|
| 24 |
+
Named features, ratio (Spearman) per draw:
|
| 25 |
+
|
| 26 |
+
| feature | version | d0 | d1 | d2 | d3 | d4 |
|
| 27 |
+
|---|---|---:|---:|---:|---:|---:|
|
| 28 |
+
| l1 | Monocyte | k1000 | 0.53 (0.45) | 1.70 (0.50) | 0.53 (0.53) | 0.71 (0.49) | 0.87 (0.50) |
|
| 29 |
+
| l1 | Monocyte | k4000 | 0.45 (0.39) | 1.72 (0.50) | 0.53 (0.52) | 0.99 (0.54) | 0.86 (0.51) |
|
| 30 |
+
| l1 | NK cell | k1000 | 0.87 (0.56) | 0.46 (0.43) | 0.46 (0.43) | 0.64 (0.46) | 0.52 (0.50) |
|
| 31 |
+
| l1 | NK cell | k4000 | 0.91 (0.59) | 0.48 (0.50) | 0.49 (0.48) | 0.67 (0.51) | 0.52 (0.58) |
|
| 32 |
+
| l1 | DC | k1000 | 0.67 (0.28) | 1.66 (0.20) | 0.43 (0.54) | 1.03 (0.56) | 0.87 (0.48) |
|
| 33 |
+
| l1 | DC | k4000 | 0.58 (0.22) | 1.73 (0.15) | 0.41 (0.53) | 1.19 (0.38) | 0.82 (0.48) |
|
| 34 |
+
| l1 | B cell | k1000 | 1.20 (0.83) | 0.56 (0.59) | 0.98 (0.75) | 0.55 (0.59) | 1.00 (0.82) |
|
| 35 |
+
| l1 | B cell | k4000 | 1.15 (0.85) | 0.59 (0.66) | 0.94 (0.78) | 0.73 (0.81) | 0.99 (0.83) |
|
| 36 |
+
| l1 | T cell | k1000 | 1.20 (0.60) | 0.92 (0.65) | 1.35 (0.29) | 1.37 (0.22) | 1.16 (0.49) |
|
| 37 |
+
| l1 | T cell | k4000 | 1.25 (0.56) | 0.92 (0.66) | 1.35 (0.31) | 1.17 (0.62) | 1.16 (0.60) |
|
| 38 |
+
| l2 | MAIT | k1000 | 0.53 (0.46) | 0.52 (0.36) | 0.55 (0.43) | 0.55 (0.38) | 0.55 (0.45) |
|
| 39 |
+
| l2 | MAIT | k4000 | 0.54 (0.52) | 0.57 (0.36) | 0.53 (0.47) | 0.49 (0.40) | 0.58 (0.51) |
|
| 40 |
+
| l2 | CD14 monocyte | k1000 | 0.53 (0.33) | 1.08 (0.46) | 0.51 (0.53) | 0.67 (0.48) | 0.76 (0.46) |
|
| 41 |
+
| l2 | CD14 monocyte | k4000 | 0.45 (0.27) | 1.20 (0.47) | 0.52 (0.54) | 1.01 (0.52) | 0.76 (0.51) |
|
| 42 |
+
| l2 | Plasma cell | k1000 | 0.38 (0.39) | 0.25 (0.22) | 0.15 (0.21) | 0.46 (0.26) | 0.43 (0.33) |
|
| 43 |
+
| l2 | Plasma cell | k4000 | 0.38 (0.40) | 0.25 (0.25) | 0.18 (0.19) | 0.78 (0.34) | 0.45 (0.31) |
|
paper-releases/pbisc-diffusion/updates/20261006T033847Z-bulkonly-lora5-k4000/diffusion/dataset/server_1/model8/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/K_BUILD.json
ADDED
|
@@ -0,0 +1,112 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"dataset": "imperial_eskd",
|
| 3 |
+
"k": 4000,
|
| 4 |
+
"cells_per_bulk": {
|
| 5 |
+
"training": "unchanged (not used by ft_sdd.py)",
|
| 6 |
+
"paired": 1500,
|
| 7 |
+
"bulkonly": 4000
|
| 8 |
+
},
|
| 9 |
+
"written_utc": "2026-10-05T17:38:27.256835+00:00",
|
| 10 |
+
"tool": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/tools/build_k_conditions.py",
|
| 11 |
+
"tool_sha256": "ef86fa3ba086ca31ada2c85d930e216608b3199da5ff0463cc17c4471ddda92b",
|
| 12 |
+
"builder": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/realbulk_generation_20260922/build_realbulk_conditions.py",
|
| 13 |
+
"builder_sha256": "e818d69e6801b5699579db7fc450590a266708d1fc2d544743e8624c9ee6a30a",
|
| 14 |
+
"prepare_dataset_sha256": "36384262b23cf6260eff645812911c1a44f791ca8e4182765d91f2aabb3ccaef",
|
| 15 |
+
"first_plan_build_conditions_sha256": "38cb97593c9a916b0dcd8d470a8c756e65c7ccc4bee6193f688e509d2e922862",
|
| 16 |
+
"depth_anchor": 3869.603120208939,
|
| 17 |
+
"checks": {
|
| 18 |
+
"training_K1000_equals_conditions_raw_fixed": true,
|
| 19 |
+
"paired_draw0_K1000_equals_test_raw": true,
|
| 20 |
+
"paired_draw1_K1000_equals_test_raw": true,
|
| 21 |
+
"paired_draw2_K1000_equals_test_raw": true,
|
| 22 |
+
"paired_draw3_K1000_equals_test_raw": true,
|
| 23 |
+
"paired_draw4_K1000_equals_test_raw": true,
|
| 24 |
+
"bulkonly_K1000_equals_bulkonly_raw": true
|
| 25 |
+
},
|
| 26 |
+
"files": {
|
| 27 |
+
"training": {
|
| 28 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/conditions_raw_fixed_K4000.npz",
|
| 29 |
+
"sha256": "d3039d2d90c19f419b797c57866ff707929f10af683fed64f13ef238d081aa0f",
|
| 30 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/paired_finetune_intradataset_20260927/data/imperial_eskd/conditions_raw_fixed.npz",
|
| 31 |
+
"source_sha256": "41a62291e98e367d05108a0a95a859ef9ca1997f1fda4656cba58eeefbe56442",
|
| 32 |
+
"rows": 172,
|
| 33 |
+
"recipe_k": 4000,
|
| 34 |
+
"cells_per_bulk": [
|
| 35 |
+
1500
|
| 36 |
+
]
|
| 37 |
+
},
|
| 38 |
+
"paired": {
|
| 39 |
+
"0": {
|
| 40 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/paired_test/draw0_test_raw_K4000.npz",
|
| 41 |
+
"sha256": "e9e22b0aa245c11864057c6a2a27c0a622d39f09f16f8d44481976f3ff7be65e",
|
| 42 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/paired_finetune_intradataset_20260927/data/imperial_eskd/fewshot_n5/draw0/test_raw.npz",
|
| 43 |
+
"source_sha256": "735672055b9222e45379a85fb0de4994028d33943ba220f048c7b6eafca65e0a",
|
| 44 |
+
"rows": 142,
|
| 45 |
+
"recipe_k": 4000,
|
| 46 |
+
"cells_per_bulk": [
|
| 47 |
+
1500
|
| 48 |
+
]
|
| 49 |
+
},
|
| 50 |
+
"1": {
|
| 51 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/paired_test/draw1_test_raw_K4000.npz",
|
| 52 |
+
"sha256": "9184925d5c7c6b5483d367fe42779684d1996c4720c19e5005a117123566ce31",
|
| 53 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/paired_finetune_intradataset_20260927/data/imperial_eskd/fewshot_n5/draw1/test_raw.npz",
|
| 54 |
+
"source_sha256": "c2293bb938f0dbf9c76063b305230e4ad0b9bec482e4fe5dfcf38a110511283f",
|
| 55 |
+
"rows": 143,
|
| 56 |
+
"recipe_k": 4000,
|
| 57 |
+
"cells_per_bulk": [
|
| 58 |
+
1500
|
| 59 |
+
]
|
| 60 |
+
},
|
| 61 |
+
"2": {
|
| 62 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/paired_test/draw2_test_raw_K4000.npz",
|
| 63 |
+
"sha256": "5751bcdd56bdee7edef0b0978193d3899becf8a8f321e1198647082cc73c13fa",
|
| 64 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/paired_finetune_intradataset_20260927/data/imperial_eskd/fewshot_n5/draw2/test_raw.npz",
|
| 65 |
+
"source_sha256": "11ba7c4e0f734b8eeab115536093d16205a1f592833e54115aa10cafd131e466",
|
| 66 |
+
"rows": 142,
|
| 67 |
+
"recipe_k": 4000,
|
| 68 |
+
"cells_per_bulk": [
|
| 69 |
+
1500
|
| 70 |
+
]
|
| 71 |
+
},
|
| 72 |
+
"3": {
|
| 73 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/paired_test/draw3_test_raw_K4000.npz",
|
| 74 |
+
"sha256": "375f75ac1f6094649e4cf0faf32c1b72bbaa82038879715b46410d8a21556921",
|
| 75 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/paired_finetune_intradataset_20260927/data/imperial_eskd/fewshot_n5/draw3/test_raw.npz",
|
| 76 |
+
"source_sha256": "1bb5ea46702a37ba35cf81b4e82426c5cfa539ef881c477be37e40621df26b7f",
|
| 77 |
+
"rows": 145,
|
| 78 |
+
"recipe_k": 4000,
|
| 79 |
+
"cells_per_bulk": [
|
| 80 |
+
1500
|
| 81 |
+
]
|
| 82 |
+
},
|
| 83 |
+
"4": {
|
| 84 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/paired_test/draw4_test_raw_K4000.npz",
|
| 85 |
+
"sha256": "73869f7b529e5c2660089321efe2bebb373a0b0efbfcf9b78eaa3509b590d339",
|
| 86 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/paired_finetune_intradataset_20260927/data/imperial_eskd/fewshot_n5/draw4/test_raw.npz",
|
| 87 |
+
"source_sha256": "55970c18927ba5d8e151bf797760d36017fffd360229507c346e39c3c6759f69",
|
| 88 |
+
"rows": 143,
|
| 89 |
+
"recipe_k": 4000,
|
| 90 |
+
"cells_per_bulk": [
|
| 91 |
+
1500
|
| 92 |
+
]
|
| 93 |
+
}
|
| 94 |
+
},
|
| 95 |
+
"bulkonly": {
|
| 96 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/bulkonly_raw_K4000.npz",
|
| 97 |
+
"sha256": "c6be369cae9e68f479af1c11eb83a8191b4a5c1a84518a755a993873c9c97434",
|
| 98 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_20261006/data/imperial_eskd/bulkonly_raw.npz",
|
| 99 |
+
"source_sha256": "4ee0c1d4332cce6d0abd135c1d438510217f74a4ca007d0b7d8ba1350e5688f6",
|
| 100 |
+
"rows": 164,
|
| 101 |
+
"recipe_k": 4000,
|
| 102 |
+
"cells_per_bulk": [
|
| 103 |
+
4000
|
| 104 |
+
]
|
| 105 |
+
},
|
| 106 |
+
"bulkonly_meta.csv": {
|
| 107 |
+
"file": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_k4000_20261006/data/imperial_eskd/bulkonly_meta.csv",
|
| 108 |
+
"sha256": "a03307389c482fb5aeb9ee439cf3ec485dfa92dc1ed7eac34350e483a84563f3",
|
| 109 |
+
"source": "/home/sj_server_1/PBISC/immun-pbmc-fm/model_8_sparse_data_diffusion/plans/bulkonly_lora5_20261006/data/imperial_eskd/bulkonly_meta.csv"
|
| 110 |
+
}
|
| 111 |
+
}
|
| 112 |
+
}
|